Courses

Overview

Do you have questions about influenza and how to approach a patient with symptoms of respiratory infection in light of the recent pandemic? Refresh your knowledge of influenza diagnosis and management for the 2021-22 flu season by checking out all 8 activities in this curated curriculum. Each activity is kept short and focused on a specific aspect of influenza management for your convenience. Select only the most relevant sessions for your needs – or click all to complete the curriculum! These expert-led sessions give you everything you need to confidently care for patients—especially those at high risk of complications—this upcoming flu season.

Learning Objectives

  1. Identify patients at high-risk of influenza complications who would benefit most from antiviral treatment or prophylaxis
  2. Discuss influenza evaluation and updates in testing
  3. Select appropriate antiviral treatment for known or suspected influenza based on indications and differences in mechanism of action, efficacy, safety, and dosing
  4. Evaluate the latest evidence-based guidelines and clinical trial data on chemoprophylaxis for influenza

Faculty 

Daniel A. Solomon, MD

Associate Physician, Division of Infectious Diseases
Brigham and Women's Hospital
Instructor of Medicine
Harvard Medical School
Boston, MA

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
Executive Director, UC Irvine Program in Medical Education for the Latino Community
UC Irvine School of Medicine
Irvine, CA

Robert H. Hopkins Jr., MD, FACP, FAAP

Professor of Internal Medicine and Pediatrics
University of Arkansas for Medical Sciences College of Medicine
Little Rock, AR

Erin D. Michos, MD, MHS

Associate Professor of Medicine & Epidemiology
Director of Women’s Cardiovascular Health
Associate Director of Preventive Cardiology
Ciccarone Center for the Prevention of Cardiovascular Disease
Johns Hopkins University School of Medicine
Baltimore, MD

Mary W. Montgomery, MD

Associate Physician, Division of Infectious Diseases
Brigham and Women's Hospital
Instructor of Medicine
Harvard Medical School
Boston, MA

Commercial Supporters

Supported by an educational grant from Genentech, a member of the Roche Group.

Education Partners

Pri-Med Institute

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation. Pri-Med Institute and Vindico Medical Education staff have no relevant financial relationships to disclose.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.